Does C-Reactive Protein Predict Recurrent Preeclampsia?

REFERENCES

• Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161(5):1200–1204.
   PubMed Web of Science ®Google Scholar
• Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180(2 Pt 1):499–506.
   PubMed Web of Science ®Google Scholar
• Borzychowski AM, Sargent IL, Redman CWG. Inflammation and pre-eclampsia. Semin Fetal Neonatal Med 2006;11(5):309–316.
   PubMed Web of Science ®Google Scholar
• Funai EF, Friedlander Y, Paltiel O, Tiram E, Xue X, Deutsch L, . Long-term mortality after preeclampsia. Epidemiology 2005;16(2):206–215.
   PubMed Web of Science ®Google Scholar
• Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. Br Med J 2001;323(7323):1213–1217.
   PubMed Web of Science ®Google Scholar
• Roberts JM, Gammill HS. Preeclampsia: Recent Insights. Hypertension 2005;46(6):1243–1249.
   PubMed Web of Science ®Google Scholar
• Tillet WS FT. Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J Exp Med 1930;52:561.
   PubMedGoogle Scholar
• Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, . Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 2004; 351(25):2599–2610.
   PubMed Web of Science ®Google Scholar
• Wolf M, Kettyle E, Sandler L, Ecker JL, Roberts J, Thadhani R. Obesity and preeclampsia: the potential role of inflammation. Obstet Gynecol 2001;98(5, Part 1): 757–762.
   Google Scholar
• Belo L, Santos-Silva A, Caslake M, Cooney J, Pereira-Leite L, Quintanilha A, . Neutrophil activation and C-reactive protein concentration in preeclampsia. Hypertens Preg 2003;22(2):129–141.
   Web of Science ®Google Scholar
• Donker RB, Molema G, Faas MM, Kallenberg CGM, van Pampus MG, Timmer A, . Absence of in vivo generalized pro-inflammatory endothelial activation in severe, early-onset preeclampsia. J Soc Gynecol Investig 2005;12(7):518–528.
   PubMedGoogle Scholar
• Ustun Y, Engin-Ustun Y, Kamaci M. Association of fibrinogen and C-reactive protein with severity of preeclampsia. Euro J Obstet Gynecol Reproduct Biol 2005;121(2):154–158.
   PubMedGoogle Scholar
• Freeman DJ, McManus F, Brown EA, Cherry L, Norrie J, Ramsay JE, . Short- and long-term changes in plasma inflammatory markers associated with preeclampsia. [Article]. Hypertension 2004;44(5):708–714.
   PubMed Web of Science ®Google Scholar
• Teran E, Escudero C, Moya W, Flores M, Vallance P, Lopez-Jaramillo P. Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with pre-eclampsia. Inter J Gynecol Obstet 2001;75(3):243–249.
   Web of Science ®Google Scholar
• Paternoster DM, Fantinato S, Stella A, Nanhorngue KN, Milani M, Plebani M, . C‐reactive protein in hypertensive disorders in pregnancy. Clin Appl Thromb/Hemos 2006;12(3):330–337.
   Google Scholar
• Kumru S, Godekmerdan A, Kutlu S, Ozcan Z. Correlation of maternal serum high-sensitive C-reactive protein levels with biochemical and clinical parameters in preeclampsia. Euro J Obstet Gynecol Reproduct Biol 2006;124(2):164–167.
   PubMedGoogle Scholar
• Deveci K, Sogut E, Evliyaoglu O, Duras N. Pregnancy-associated plasma protein-A and C‐reactive protein levels in pre-eclamptic and normotensive pregnant women at third trimester. J Obstet Gynaecol Res 2009;35(1):94–98.
   PubMed Web of Science ®Google Scholar
• Tjoa ML, van Vugt JMG, Go ATJJ, Blankenstein MA, Oudejans CBM, van Wijk IJ. Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction. J Reprod Immunol 2003;59(1):29–37.
   PubMed Web of Science ®Google Scholar
• Savvidou MD, Lees CC, Parra M, Hingorani AD, Nicolaides KH. Levels of C-reactive protein in pregnant women who subsequently develop pre-eclampsia. BJOG: An Inter J Obstet Gynaecol 2002;109(3):297–301.
   Google Scholar
• Qiu C, Luthy DA, Zhang C, Walsh SW, Leisenring WM, Williams MA. A prospective study of maternal serum C-reactive protein concentrations and risk of preeclampsia. Am .J Hypertens 2004;17(2):154–160.
   PubMed Web of Science ®Google Scholar
• Garci'a RG, Celedon J, Sierra-Laguado J, Alarcon MA, Luengas C, Silva F, . Raised C‐Reactive protein and impaired flow-mediated vasodilation precede the development of preeclampsia. Am J Hypertens 2007;20(1):98–103.
   Google Scholar
• Djurovic S, Clausen T, Wergeland R, Brosstad F, Berg K, Henriksen T. Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre-eclampsia. BJOG: An Inter J Obstet Gynaecol 2002;109(7): 759–764.
   PubMed Web of Science ®Google Scholar
• Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M, Thom E, . Low‐dose aspirin to prevent preeclampsia in women at high risk. N Engl J Med 1998;338(11):701–705.
   PubMed Web of Science ®Google Scholar
• Teran E, Escudero C, Calle A. C-reactive protein during normal pregnancy and preeclampsia. International J Gynecol Obstet 2005;89(3):2997–300.
   Google Scholar
• Black S, Kushner I, Samols D. C-reactive protein. J Biol Chem 2004;279(47): 48487–48490.
   PubMed Web of Science ®Google Scholar
• Marnell L, Mold C, Du Clos TW. C-reactive protein: Ligands, receptors and role in inflammation. Clin Immunol 2005;117(2):104–111.
   Google Scholar
• Hubel CA, Powers RW, Snaedal S, Gammill HS, Ness RB, Roberts JM, . C‐reactive protein is elevated 30 years after eclamptic pregnancy. Hypertension 2008;51(6):1499–1505.
   Google Scholar
• Portelinha A, Belo Ls, Tejera E, Rebelo I. Adhesion molecules (VCAM-1 and ICAM-1) and C‐reactive protein in women with history of preeclampsia. Acta Obstet Gynecol Scand 2008;87(9):969–971.
   PubMed Web of Science ®Google Scholar
• Smith GN, Walker MC, Liu A, Wen SW, Swansburg M, Ramshaw H, . A history of preeclampsia identifies women who have underlying cardiovascular risk factors. Am J Obstet Gynecol 2009;200(1):58.e1–58.e8.
   Google Scholar
• Sattar N, Ramsay J, Crawford L, Cheyne H, Greer IA. Classic and novel risk factor parameters in women with a history of preeclampsia. Hypertension 2003;42(1):39–42.
   PubMed Web of Science ®Google Scholar
• Benyo DF, Smarason A, Redman CW, Sims C, Conrad KP. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab 2001; 86(6):2505–2512.
   PubMed Web of Science ®Google Scholar
• Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, . Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-{alpha}, in Vivo. J Clin Endocrinol Metab 1997;82(12):4196–4200.
   PubMed Web of Science ®Google Scholar
• Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW. C-reactive protein in wealthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction—A potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vascul Biol 1999; 19(4):972–978.
   PubMed Web of Science ®Google Scholar
• Conrad KP, Miles TM, Benyo DF. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol 1998;40(2):102–111.
   PubMed Web of Science ®Google Scholar
• Bodnar LM, Ness RB, Harger GF, Roberts JM. Inflammation and triglycerides partially mediate the effect of prepregnancy body mass index on the risk of preeclampsia. Am J Epidemiol 2005;162(12):1198–1206.
   PubMed Web of Science ®Google Scholar
• Belo L, Santos-Silva A, Rocha S, Caslake M, Cooney J, Pereira-Leite L, . Fluctuations in C-reactive protein concentration and neutrophil activation during normal human pregnancy. Euro J Obstet Gynecol Reproduct Biol 2005;123(1):46–51.
   PubMed Web of Science ®Google Scholar
• Bertran N, Camps J, Fernandez-Ballart J, Murphy MM, Arija V, Ferre N, . Evaluation of a high-sensitivity turbidimetric immunoassay for serum C-reactive protein: application to the study of longitudinal changes throughout normal pregnancy. Clin Chem Lab Med 2005;43(3):308–313.
   Google Scholar
• Picklesimer AH, Jared HL, Moss K, Offenbacher S, Beck JD, Boggess KA. Racial differences in C-reactive protein levels during normal pregnancy. Am J Obstet Gynecol 2008;199(5): 523.e1–523.e6.
   Google Scholar
• Khera A, McGuire DK, Murphy SA, Stanek HG, Das SR, Vongpatanasin W, . Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 2005;46(3):464–469.
   PubMed Web of Science ®Google Scholar
• Woloshin S, Schwartz LM. Distribution of C-Reactive Protein Values in the United States. N Engl J Med 2005;352(15):1611a–1613.
   PubMed Web of Science ®Google Scholar
• Ledue TB, Rifai N. Preanalytic and analytic sources of variations in C-reactive protein measurement: Implications for cardiovascular disease risk assessment. Clin Chem 2003;49(8): 1258–1271.
   PubMed Web of Science ®Google Scholar